Abstract
Phosphorylcholine-based polymers have been used commercially to improve the biocompatibility of coronary stents. In this study, one particular polymer is assessed for its suitability as a drug delivery vehicle. Membranes of the material are characterized in terms of water content and molecular weight cut-off, and the presence of hydrophilic and hydrophobic domains investigated by use of the hydrophobic probe pyrene. The in vitro loading and elution of a variety of drugs was assessed using stents coated with the polymer. The rate of a drug's release was shown not to be simply a function of its water solubility, but rather more closely related to the drug oil/water partition coefficient. This finding was explained in terms of the more hydrophobic drugs partitioning into, and interacting with, the hydrophobic domains of the polymer coating. The suitability of the coated stent as a drug delivery vehicle was assessed in vivo using a radiolabeled analog of one of the more rapidly eluting drugs, angiopeptin. Autoradiography showed that the drug was released locally to the wall of the stented artery, and could be detected up to 28 days after implantation.
© 2001 Kluwer Academic Publishers
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
A. L. Lewis, P. W. Stratford, A. L. Lewis, R. T. Freeman, L. Hughes, R. P. Redman, L. A. Tolhurst and T. A. Vick, Abstracts of UKSB 1st Annual Conference, July 2000.
A. L. Lewis, Colloids Surf. B: Biointerfaces 18 (2000) 261.
W. J. Van der Giessen, A. M. Lincoff, R. S. Schwartz, H. M. M. Van Beusekom, P. W. Serruys, D. R. Holmes, S. G. Ellis and E. J. Topol, Circulation 94(7) (1996) 1690.
A. L. Lewis, L. A. Tolhurst and P. W. Stratford, Biomaterials in press (2001).
A. M. McNair, Med. Dev. Tech. 7(10) (1996) 16.
A. L. Lewis, Z. L. Cumming, H. H. Goreish, L. C. Kirkwood, L. A. Tolhurst and P. W. Stratford Biomaterials 22 (2001) 99.
E. F. Murphy, J. R. Lu, A. L. Lewis, J. Brewer, J. Russell and P. W. Stratford, Macromolecules 33(12) (2000) 4545.
S. L. Willis, J. L. Court, R. P. Redman, J. H. Wang, S. W. Leppard, V. O'byrane, S. A. Small, A. L. Lewis, S. A. Jones and P. W. Stratford Biomaterials in the press.
K. Kalyanasundaram and J. K. Thomas, J. Am. Chem. Soc. 99(7) (1977) 2039.
K. Ishihara, Y. Iwasaki and N. Nakabayashi, Polym. J. 31(12) (1999) 1231.
J. Gunn, Oral presentation, 6th Int. LDD&R Mtg, January 2000.
P. H. Corkhill, A. M. Jolly, C. O. Ng and B. J. Tighe, Polymer 28 (1987) 1758.
Y. Tang, J. R. Lu, A. L. Lewis, T. A. Vick and P. W. Stratford Macromolecules (2001) submitted.
CE mark for the BiodivYsio ™ Matrix HI drug delivery stent system, 2001.
M. L. Foegh, S. Asotra, J. V. Conte, M. Howell, E. Kagan, K. Verma and P. W. Ramwell, J. Vasc. Surg. 19 (1994) 1084.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lewis, A.L., Vick, T.A., Collias, A.C.M. et al. Phosphorylcholine-based polymer coatings for stent drug delivery. Journal of Materials Science: Materials in Medicine 12, 865–870 (2001). https://doi.org/10.1023/A:1012803503667
Issue Date:
DOI: https://doi.org/10.1023/A:1012803503667